key: cord-0869214-1jubsy23
authors: Bruusgaard-Mouritsen, Maria A.; Koo, Grace; Heinrichsen, Anne Sophie; Melchiors, Birgitte Bech; Krantz, Matthew S.; Plager, Jessica H.; Boxer, Mitchell; Phillips, Elizabeth J.; Stone, Cosby A.; Garvey, Lene H.
title: Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy
date: 2022-01-01
journal: J Allergy Clin Immunol Pract
DOI: 10.1016/j.jaip.2021.12.025
sha: 6b9a39e5afea61ba5f00fa2e0ea0d1176f378f83
doc_id: 869214
cord_uid: 1jubsy23

nan

The safety of COVID-19 vaccination in patients with confirmed polyethylene glycol (PEG) allergy, with or without skin test sensitization to the PEG-derivative polysorbate 80, is 59 unknown. We report tolerance of the polysorbate 80-containing Janssen adenoviral vector vaccine in 60 ten PEG-allergic patients.

Polyethylene glycols (PEGs) and the structurally related polysorbates (PEG sorbitans -PEG 

Intradermal testing with methylprednisolone acetate was only used if SPT testing was negative across all reagents (see ref 7). c SPT: A positive reaction was defined as a wheal diameter of > 3 mm. IDT: A positive reaction was defined as a wheal ≥ saline wheal+3 mm and flare. d SPT prior to vaccination was performed with the three COVID 19-vaccines from Pfizer, Moderna and Janssen "as is". DK cases were additionally skin prick tested with PEG 2000 (500 mg/ml)